9 August 2016 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) is seeking further comments on a potential user-fee programme for OTC monograph drugs. The regulatory agency is also running a webinar to update stakeholders on its talks with the Consumer Healthcare Products Association (CHPA).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.